We decided to discontinue this particular clinical study through internal discussion.

The purpose of this study is to evaluate the food effect on the pharmacokinetics of DWJ1458 after oral administration in healthy volunteers.

The purpose of this study is to evaluate the food effect on the pharmacokinetics of DWJ1458 after oral administration in healthy volunteers: Randomized, open-label, oral, single-dose, crossover study

Inclusion Criteria:

• Age 19 to 55 years
• BMI 18.5≥ and ≤27.0 kg/m²
• Female subjects must be menopause or surgically infertility.
• Male subjects must consent to contraception for at least 60 days after the study period and the final administration of the study drug.
• Those who understand the requirements of the study and sign a written informed consent, and also accept all the restrictions imposed during the course of the study.

Exclusion Criteria:

• History of hypersensitivity to investigational product
• Participation in a clinical drug study or bioequivalence study 6 months prior to the present study
• The subject who is judged to be unsuitable as a test subject in a screening test.
• The subject who is judged to be unsuitable for participation in a clinical trial due to other reasons determined by the investigators.